Paper4200532
Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis.
Hughes WT and 3 others. Curr Ther Res Clin Exp, 1973. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Papers, record 4200532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4200532
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pneumonia, Pneumocystis | Major topic |
| Amidines | |
| Animals | |
| Cortisone | |
| Immunization | |
| Male | |
| Pyrimethamine | |
| Rats | |
| Sulfonamides | |
| Time Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22451747 | Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS. | Can J Infect Dis | 1991 | https://conductscience.org/library/papers/22451747 | PubMed |
| 10066645 | Immunological features of Pneumocystis carinii infection in humans. | Clin Diagn Lab Immunol | 1999 | https://conductscience.org/library/papers/10066645 | PubMed |
| 7790048 | Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. | Infect Immun | 1995 | https://conductscience.org/library/papers/7790048 | PubMed |
| 6966614 | Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. | Infect Immun | 1980 | https://conductscience.org/library/papers/6966614 | PubMed |
| 6334032 | Predisposing factors in Pneumocystis carinii pneumonia: effects of tetracycline, protein malnutrition, and corticosteroids on hosts. | Infect Immun | 1984 | https://conductscience.org/library/papers/6334032 | PubMed |
| 4365115 | Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4365115 | PubMed |
| 3552596 | Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. | Drugs | 1987 | https://conductscience.org/library/papers/3552596 | PubMed |
| 3494426 | Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3494426 | PubMed |
| 3260765 | Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3260765 | PubMed |
| 307941 | Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/307941 | PubMed |
| 307535 | Propagation of Pneumocystis carinii in Vero cell culture. | Infect Immun | 1978 | https://conductscience.org/library/papers/307535 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4200532
GET https://conductscience.org/api/papers/v1/4200532/authors